
This medication is compounded by a licensed 503A pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act, and may only be dispensed pursuant to a valid, patient-specific prescription issued by a licensed healthcare practitioner following an individualized medical evaluation. The FDA does not review or approve compounded medications, including compounded tirzepatide, for safety, effectiveness, or quality. Compounded tirzepatide has not been FDA-approved for weight loss or any other indication, though peer-reviewed and third-party research suggests potential clinical benefits. Individual results will vary. This compounded formulation is not affiliated with, endorsed by, reviewed by, or intended to replace any FDA-approved product manufactured by Eli Lilly and Company. EOS Health and its pharmacy partners have no affiliation with Eli Lilly and Company.
Compounded Tirzepatide + B12 combines a dual-action GLP-1 and GIP medication with vitamin B12 in a single weekly injection. The tirzepatide works to regulate blood sugar, curb appetite, and slow digestion, while added B12 helps maintain the energy levels that keep an active routine on track through weight loss.
Significant Weight Loss: Clinical studies of tirzepatide have demonstrated an average body weight reduction of 15% to 22% when combined with lifestyle modifications.
Steady Daily Energy: Added vitamin B12 supports red blood cell production and energy metabolism, helping offset the fatigue that can accompany a reduced-calorie routine.
Enhanced Appetite Suppression: Dual-receptor activation signals the brain to increase satiety, helping patients manage portion sizes naturally.
Delayed Gastric Emptying: It slows the digestive process, prolonging fullness and minimizing cravings throughout the day.
Blood Sugar Control: By stimulating insulin secretion and reducing glucagon production, it stabilizes blood sugar and prevents post-meal energy crashes.